Evaluating Cost-Effectiveness of First-Line Immune Checkpoint Inhibition in Melanoma
For treatment of BRAF wild-type, stage IV melanoma, first-line immune checkpoint inhibition is more cost-effective than chemotherapy.
All articles by Andrea S. Blevins Primeau
More Research Needed on Skin Cancer Control
There are still many gaps in behavioral research, for skin cancer control.
Dermatoscopic Characteristics of Seborrheic Keratosis-Like Melanoma
SK-like melanoma are hard to diagnose, however dermoscopic features can help diagnose them.
- Loading...
Loading...
Next post in Skin Cancer
Loading... 
Loading...